{"id":518050,"date":"2021-07-27T08:03:59","date_gmt":"2021-07-27T12:03:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"modified":"2021-07-27T08:03:59","modified_gmt":"2021-07-27T12:03:59","slug":"cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","title":{"rendered":"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <em>Investors with losses are encouraged to contact the firm before <\/em><br \/>\n        <em>September 20, 2021<\/em><br \/>\n        <em>; click <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5p_LTPbAYZI75-doZrIhwQZV1W_kQTMkGvw3s5uzHCAzRwhG_DwXbL0jTMQKAnL-Mvzrcp22JmYg07U6EgIe2Q==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <em><br \/>\n            <u>here<\/u><br \/>\n          <\/em><br \/>\n        <\/a><br \/>\n        <em> to submit trade information<\/em><br \/>\n        \n      <\/p>\n<p>LOS ANGELES, July  27, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EC1DgMC8vre-yDCciAz-uBUnzh1byr0D2I6XOdqoYf8q8HqG5DtdUeZLY1ooEx2F4Gv8Dx6D6aikRqoIAXys3u3R2sI1LCtl_0w6xWl9LmQ=\" rel=\"nofollow noopener\" target=\"_blank\"><u>The Portnoy Law Firm<\/u><\/a> advises investors that a class action lawsuit has been filed on behalf of CorMedix, Inc. (NASDAQ: CRMD) investors that acquired shares between July 8, 2020 and May 13, 2021. Investors have until September 20, 2021 to seek an active role in this litigation.<\/p>\n<p>Investors are encouraged to contact attorney <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HabJF5TtC6-Fj8m4hu7Fecu9rMoai2RD9aM2FFN1LIyGzyITHFn9YJ5u_pOdMdaNeAa1SMnd-V68URiwdW3E4Hm89jcJYpF4UBOpZ7UWlDQ=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Lesley F. Portnoy<\/u><\/a><u>,<\/u> to determine eligibility to participate in this action, by phone 310-692-8883 or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OfFHvZzwWWTLKHz3EmVmqqR2nDbdWMoJYAmd2KPZT19AXTtLbvr2NexmOWtyEqvoCg1Hnz3SDzlXGrk08vRegaFbKxiGWM-YnhFjUUr4Hrg=\" rel=\"nofollow noopener\" target=\"_blank\"><u>email<\/u><\/a>, or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kbVAdTNhwXjxIjoXD1bFoOxCTqHk1AGRWWiVfQDjsJiPA954fogCFCX0zMUYnEHMOFrrkxJTGI1gvkNYBGBltg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>click here<\/u><\/a> to join the case.<\/p>\n<p>It is alleged in this complaint that CorMedix made misleading and false statements to the market. CorMedix suffered from deficiencies in relation to DefenCath\u2019s manufacturing process. Based on these deficiencies, it was unlikely that the FDA would approve CorMedix\u2019 NDA for DefenCath. The Company downplayed the extent of these manufacturing problems in its public statements. CorMedix\u2019 public statements were materially misleading and false throughout the class period, based on these facts. Investors suffered damages when the market learned the truth about CorMedix.<\/p>\n<p>A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 20, 2021.<\/p>\n<p>Please visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IhN-zIiiZucrWDLfia8rhFTexy43u0KAZqMs-KzyaSpzkTxnn36pmo1iCAa8Srtn6Xa62aAPNuA_Xx58C4Wc_A==\" rel=\"nofollow noopener\" target=\"_blank\"><u>website<\/u><\/a> to review more information and submit your transaction information.<\/p>\n<p>The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm\u2019s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Lesley F. Portnoy, Esq.<br \/>Admitted CA and NY Bar<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GKt3HsqSGGGmAUk63Qrv4VE9p8DOD2iuyOjvy68nfeqSoT-kWBR0hWWy0bEdlvgDK5lFvtGw7hi5W5dCaLZew9Y3n8EGjJ5TfEWAa6Aa31g=\" rel=\"nofollow noopener\" target=\"_blank\"><u>lesley@portnoylaw.com<\/u><\/a><br \/>310-692-8883<br \/>www.portnoylaw.com<\/p>\n<p>Attorney Advertising<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b83abccd-d243-4792-9af0-4e7fbb872faf\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Investors with losses are encouraged to contact the firm before September 20, 2021 ; click here to submit trade information LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) &#8212; The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of CorMedix, Inc. (NASDAQ: CRMD) investors that acquired shares between July 8, 2020 and May 13, 2021. Investors have until September 20, 2021 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged in this complaint that CorMedix made misleading and false statements to the market. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-518050","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Investors with losses are encouraged to contact the firm before September 20, 2021 ; click here to submit trade information LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) &#8212; The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of CorMedix, Inc. (NASDAQ: CRMD) investors that acquired shares between July 8, 2020 and May 13, 2021. Investors have until September 20, 2021 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged in this complaint that CorMedix made misleading and false statements to the market. &hellip; Continue reading &quot;CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T12:03:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\",\"datePublished\":\"2021-07-27T12:03:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"},\"wordCount\":284,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\",\"name\":\"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=\",\"datePublished\":\"2021-07-27T12:03:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk","og_description":"Investors with losses are encouraged to contact the firm before September 20, 2021 ; click here to submit trade information LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) &#8212; The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of CorMedix, Inc. (NASDAQ: CRMD) investors that acquired shares between July 8, 2020 and May 13, 2021. Investors have until September 20, 2021 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged in this complaint that CorMedix made misleading and false statements to the market. &hellip; Continue reading \"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-27T12:03:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm","datePublished":"2021-07-27T12:03:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"wordCount":284,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","name":"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=","datePublished":"2021-07-27T12:03:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIxMyM0MzE2MTA1IzIxOTU1Mjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CorMedix, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=518050"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518050\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=518050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=518050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=518050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}